Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

People on dialysis for kidney disease are 100 time more likely than others to get staph dangerous hospital- acquired infections in their blood. Nearly 15,000 dialysis patients got blood stream infections in 2020, a third of which were staph (infections of a bacteria called Staphylococcus aureus). While the number of infections has decreased since 2014, the risk remains, and disparities are prevalent. Black and Hispanic patients are more likely than their white counterparts on dialysis to get a staph in their bloodstream, according to a Centers for Disease Control and Prevention (CDC) report published February 6, 2023. You’ve been admitted…

Read More

​Early in Dee Mangin’s career as a primary-care physician, she noticed that many people, especially older adults, were prescribed large numbers and doses of drugs, which, in some cases, might actually be detracting from their health rather than improving it. Then, she realized that even when polypharmacy (being prescribed five or more medications simultaneously) was recognized as a problem, there wasn’t any systematic way to help patients and healthcare providers assess which medicines might be most effective in a lower dose or discontinued altogether.  Mangin is an MBChB (the New Zealand equivalent of an MD) and DPH (doctor of public…

Read More